Agenus | AGEN - Ebit





Ebit Veränderung Datum
AbbVie USD 6.72B 1.99B 2026-06
Agenus USD 15.05M 656K 2026-03
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Celldex Therapeutics USD -80.62M 3.81M 2026-06
CSL USD 2.64B 116M 2025-12
Eli Lilly USD 12.46B 2.68B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Glaxosmithkline GBP 2.31B 14.92M 2026-03
Incyte USD 700.4M 356.23M 2026-06
Intrexon USD -26.3M 2.91M 2024-06
J&J USD 7.48B 860M 2026-06
Jiangsu Hengrui CNY 2.56B 302M 2026-03
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -31.88M 19.79M 2026-03
Merck EUR 1.1B 51M 2026-06
Merck USD 840M 2.72B 2026-06
Northwest Biotherapeutics USD -10.9M 3.42M 2026-03
Novartis USD 4.73B 549M 2026-06
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD -180M 5.16B 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Veracyte USD 23.96M 4.88M 2026-06